SOCS1 and rheumatoid arthritis: Despite a significant decrease in disease activity as a result of treatment adjusted over time (Figure 1A, Supplementary Table 3), we observed a significant reduction in SOCS1 mRNA expression during follow-up of patients with UA (Figure 1B; p = 0.013), but no significant changes in SOCS1 mRNA expression in patients with RA.